DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Guanfacine Hydrochloride is a drug marketed by Actavis Elizabeth, Apotex, Impax Labs Inc, Mylan, Sandoz Inc, Sun Pharm, Teva Pharms Usa, Twi Pharms, Yichang Humanwell, Amneal Pharm, Epic Pharma Llc, Unichem, and Watson Labs. and is included in fifteen NDAs.
The generic ingredient in GUANFACINE HYDROCHLORIDE is guanfacine hydrochloride. There are seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the guanfacine hydrochloride profile page.
A generic version of GUANFACINE HYDROCHLORIDE was approved as guanfacine hydrochloride by WATSON LABS on October 17th, 1995.
Summary for GUANFACINE HYDROCHLORIDE
|Finished Product Suppliers / Packagers:||20|
|Raw Ingredient (Bulk) Api Vendors:||94|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for GUANFACINE HYDROCHLORIDE|
|DailyMed Link:||GUANFACINE HYDROCHLORIDE at DailyMed|
Recent Clinical Trials for GUANFACINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Massachusetts General Hospital||Phase 2|
|University of Alabama at Birmingham||N/A|
|Stanford University||Phase 4|